JP2024001073A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024001073A5 JP2024001073A5 JP2023165289A JP2023165289A JP2024001073A5 JP 2024001073 A5 JP2024001073 A5 JP 2024001073A5 JP 2023165289 A JP2023165289 A JP 2023165289A JP 2023165289 A JP2023165289 A JP 2023165289A JP 2024001073 A5 JP2024001073 A5 JP 2024001073A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023165289A JP2024001073A (ja) | 2017-10-24 | 2023-09-27 | 抗グリコｍｕｃ１抗体およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2017/058036 WO2019083506A1 (en) | 2017-10-24 | 2017-10-24 | ANTI-GLYCO-MUC1 ANTIBODIES AND USES THEREOF |
| JP2020543460A JP7358367B2 (ja) | 2017-10-24 | 2017-10-24 | 抗グリコｍｕｃ１抗体およびその使用 |
| JP2023165289A JP2024001073A (ja) | 2017-10-24 | 2023-09-27 | 抗グリコｍｕｃ１抗体およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543460A Division JP7358367B2 (ja) | 2017-10-24 | 2017-10-24 | 抗グリコｍｕｃ１抗体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024001073A JP2024001073A (ja) | 2024-01-09 |
| JP2024001073A5 true JP2024001073A5 (enExample) | 2024-04-24 |
Family
ID=66247577
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543460A Active JP7358367B2 (ja) | 2017-10-24 | 2017-10-24 | 抗グリコｍｕｃ１抗体およびその使用 |
| JP2023165289A Pending JP2024001073A (ja) | 2017-10-24 | 2023-09-27 | 抗グリコｍｕｃ１抗体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543460A Active JP7358367B2 (ja) | 2017-10-24 | 2017-10-24 | 抗グリコｍｕｃ１抗体およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3700936A4 (enExample) |
| JP (2) | JP7358367B2 (enExample) |
| KR (2) | KR102608763B1 (enExample) |
| CN (1) | CN111479828B (enExample) |
| AU (1) | AU2017436815B2 (enExample) |
| BR (1) | BR112020008001A2 (enExample) |
| CA (1) | CA3078812A1 (enExample) |
| IL (1) | IL274202A (enExample) |
| MX (1) | MX2020004220A (enExample) |
| WO (1) | WO2019083506A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3078812A1 (en) * | 2017-10-24 | 2019-05-02 | Go Therapeutics, Inc. | Anti-glyco-muc1 antibodies and their uses |
| WO2022026809A1 (en) * | 2020-07-31 | 2022-02-03 | R.P. Scherer Technologies, Llc | Antibody specific for mucin-1 and methods of use thereof |
| IL311090A (en) * | 2021-08-27 | 2024-04-01 | Peptron Inc | A novel ANTI-MUC1 antibody and its use |
| US20230250190A1 (en) * | 2021-12-21 | 2023-08-10 | Merus N.V. | Binding domains against cancer-associated muc1 |
| CN115068610B (zh) * | 2022-01-27 | 2024-04-16 | 中国农业大学 | 抑制乳腺癌细胞中muc1表达的物质在降低抗乳腺癌药物耐药性中的应用 |
| EP4696711A1 (en) * | 2023-04-13 | 2026-02-18 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Antigen binding molecule specifically binding to egfr and muc1, drug conjugate thereof, and medical use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020146750A1 (en) * | 2000-03-30 | 2002-10-10 | Hoogenboom Hendricus R.J.M. | Mucin-1 specific binding members and methods of use thereof |
| DE10303664A1 (de) * | 2003-01-23 | 2004-08-12 | Nemod Immuntherapie Ag | Erkennungsmoleküle zur Behandlung und Detektion von Tumoren |
| US8440798B2 (en) * | 2006-10-04 | 2013-05-14 | Københavns Universitet | Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies |
| EP2014302A1 (en) * | 2007-07-12 | 2009-01-14 | Institut Curie | An antibody specific for the Tn antigen for the treatment of cancer |
| AU2008332296A1 (en) * | 2007-12-05 | 2009-06-11 | Kyowa Hakko Kirin Co., Ltd. | Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| JP5773352B2 (ja) * | 2008-10-28 | 2015-09-02 | 塩野義製薬株式会社 | 抗ｍｕｃ１抗体 |
| EP2281844A1 (en) * | 2009-07-31 | 2011-02-09 | Glycotope GmbH | MUC 1 antibodies |
| US10208125B2 (en) * | 2013-07-15 | 2019-02-19 | University of Pittsburgh—of the Commonwealth System of Higher Education | Anti-mucin 1 binding agents and uses thereof |
| WO2015120180A1 (en) * | 2014-02-05 | 2015-08-13 | The University Of Chicago | Chimeric antigen receptors recognizing cancer-specific tn glycopeptide variants |
| US10239950B2 (en) * | 2014-04-28 | 2019-03-26 | Medicinal Chemistry Pharmaceuticals, Co., Ltd. | Anti-MUC1 antibody or antigen-binding fragment thereof and uses thereof |
| CA3078812A1 (en) * | 2017-10-24 | 2019-05-02 | Go Therapeutics, Inc. | Anti-glyco-muc1 antibodies and their uses |
-
2017
- 2017-10-24 CA CA3078812A patent/CA3078812A1/en active Pending
- 2017-10-24 KR KR1020207014390A patent/KR102608763B1/ko active Active
- 2017-10-24 KR KR1020237040745A patent/KR102832078B1/ko active Active
- 2017-10-24 AU AU2017436815A patent/AU2017436815B2/en active Active
- 2017-10-24 BR BR112020008001-2A patent/BR112020008001A2/pt unknown
- 2017-10-24 CN CN201780097773.8A patent/CN111479828B/zh active Active
- 2017-10-24 EP EP17929557.1A patent/EP3700936A4/en active Pending
- 2017-10-24 JP JP2020543460A patent/JP7358367B2/ja active Active
- 2017-10-24 WO PCT/US2017/058036 patent/WO2019083506A1/en not_active Ceased
- 2017-10-24 MX MX2020004220A patent/MX2020004220A/es unknown
-
2020
- 2020-04-23 IL IL274202A patent/IL274202A/en unknown
-
2023
- 2023-09-27 JP JP2023165289A patent/JP2024001073A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024001073A5 (enExample) | ||
| EP4039707A1 (en) | Cd3-targeting antibody, bispecific antibody and use thereof | |
| EP3353213B1 (en) | Anti-mesothelin antibody and composition comprising the same | |
| JP2019116474A5 (enExample) | ||
| AU2020352382A1 (en) | Anti-human claudin 18.2 antibody and application thereof | |
| JP2019527553A5 (enExample) | ||
| JP2021503455A5 (enExample) | ||
| AU2018218753A1 (en) | Anti-GPRC5D antibody and molecule containing same | |
| JP2013502913A5 (enExample) | ||
| KR20220111308A (ko) | 인간화 cldn18.2 항체 | |
| JPWO2020114480A5 (enExample) | ||
| AU2017379382A1 (en) | Anti-CD3 Antibody and Molecules Comprising the Antibody | |
| JP7821159B2 (ja) | Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子 | |
| EP4155320A1 (en) | Anti-b7h4 antibody, and bispecific antibody and use thereof | |
| TW202241944A (zh) | 新穎的抗ｇｒｅｍｌｉｎ１抗體 | |
| JP2020522488A5 (enExample) | ||
| CN106243223B (zh) | 抗人pdl1抗体及其用途 | |
| CN113574069A (zh) | 抗pd-l1抗体及其用途 | |
| US12577314B2 (en) | Anti-BCMA/anti-4-1BB bispecific antibodies and uses thereof | |
| JPWO2019185040A5 (enExample) | ||
| CN112805297B (zh) | 抗人类pd-l1抗体及其用途 | |
| JPWO2022104236A5 (enExample) | ||
| JPWO2022051591A5 (enExample) | ||
| JP7641292B2 (ja) | 抗ｃｄ１９抗体、その使用方法及び製造方法 | |
| JPWO2022159984A5 (enExample) |